KL and cancer: Kla specifically activates immune checkpoint (including PD-L1), oncogenes, factors linked to the epithelial-mesenchymal transition (EMT), and drug resistance gene transcription programs, all of which completely alter the drug-resistant phenotype of cancer cells.